Clínica de Marly S.A. (BVC:MARLY)
Colombia · Delayed Price · Currency is COP 8,500.00
0.00 (0.00%)
At close: Jul 31, 2026
Clínica de Marly Cash Flow Statement
Financials in millions COP. Fiscal year is January - December.
Millions COP. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 89,820 | 87,435 | 87,735 | 64,681 | 54,581 | 48,974 |
Depreciation & Amortization | 6,287 | 5,980 | 5,705 | 5,531 | 5,786 | 5,447 |
Other Operating Activities | -58,605 | -38,674 | -84,433 | -38,027 | -14,244 | -22,334 |
Operating Cash Flow | 37,502 | 54,740 | 9,006 | 32,185 | 46,123 | 32,088 |
Operating Cash Flow Growth | 270.82% | 507.79% | -72.02% | -30.22% | 43.74% | 6.18% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -20,753 | -23,476 | -9,429 | -8,885 | -18,628 | -15,583 |
Sale of Property, Plant & Equipment | - | - | 950 | 599.27 | 2,265 | 441.01 |
Other Investing Activities | 7,289 | -5,747 | 9,472 | 5,017 | 20,307 | -1,083 |
Investing Cash Flow | -13,465 | -29,223 | 992.38 | -3,269 | 3,944 | -16,225 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 30,583 |
Long-Term Debt Repaid | - | -2,924 | -8,396 | -8,396 | -9,033 | -36,472 |
Net Debt Issued (Repaid) | -824.65 | -2,924 | -8,396 | -8,396 | -9,033 | -5,889 |
Issuance of Common Stock | - | - | - | - | - | 6,805 |
Common Dividends Paid | -28,077 | -27,333 | -12,295 | -7,522 | -48,345 | -3,805 |
Other Financing Activities | 492.14 | 423.41 | -965.31 | -2,245 | -2,285 | -386.31 |
Financing Cash Flow | -28,410 | -29,834 | -21,656 | -18,163 | -59,663 | -3,275 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -11.65 | -14.42 | 12.99 | -10.18 | 17.24 | - |
Net Cash Flow | -4,384 | -4,331 | -11,644 | 10,743 | -9,578 | 12,588 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 16,748 | 31,264 | -422.9 | 23,300 | 27,495 | 16,504 |
Free Cash Flow Growth | - | - | - | -15.26% | 66.59% | -26.75% |
Free Cash Flow Margin | 3.79% | 7.17% | -0.10% | 6.42% | 8.56% | 5.92% |
Free Cash Flow Per Share | - | - | - | 2182.04 | 2574.90 | 1545.65 |
Levered Free Cash Flow | 35,763 | 55,490 | 67,875 | 45,983 | 16,482 | 23,894 |
Unlevered Free Cash Flow | 35,852 | 55,624 | 68,727 | 47,436 | 17,861 | 24,899 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 5.66 | 68.9 | 965.31 | 2,258 | 2,466 | 1,420 |
Cash Income Tax Paid | 26,965 | 26,183 | 19,852 | 14,120 | 9,269 | 2,674 |